Skip to main content

Table 1 Oligonucleotides used for the amplification of full-length or deletion mutants of Crmyc2 or for the reconstitution of sequences encoding the putative NLSs of the CrMYC2 protein

From: Three non-autonomous signals collaborate for nuclear targeting of CrMYC2, a Catharanthus roseus bHLH transcription factor

Fusion protein

name

Nucleotide sequences of primers used to amplify the Crmyc2 fragments or to reconstitute the short coding sequences of the NLSs

CrMYC2

forward

5'-CCGCTCGAG ATGACGGACTAT-3'

 

reverse

5'-CCGCTCGAG TCATACCAAGAG-3'

F1

forward

5'-CCGCCATGG GCACCGCCGATGATGCA-3'

 

reverse

5'-CCGCCATGG GTACCAAGAGCCTCATCG-3'

F2

forward

5'-CCGCCATGG GGGTAGTTTTGCCCTCTACT-

 

reverse

5'-CCGACTAGT TACCAAGAGCCTCATCGAGT-3'

F3

forward

5'-CCGCCATGG GAAGGGAAGAGCCATTGAAT-3'

 

reverse

5'-CCGACTAGT TACCAAGAGCCTCATCGAGT-3'

F4

forward

5'-CCGCCATGG GGGTAGTTTTGCCCTCTACT-3'

 

reverse

5'-CCGCCATGG CCATTTGCAGGCTTTCTCCC 3'

F5

forward

5'-CCGCCATGG GAAGGGAAGAGCCATTGAAT-3'

 

reverse

5'-CCGACTAGT TAATTCAAGATCAAGAT-3'

F6

forward

5'-CCGCCATGG GAAGGGAAGAGCCATTGAAT-3'

 

reverse

5'-CCGACTAGT ATCAATATCCATATCCAAGTTACC-3'

F7

forward

5'-CCGCCATGG GTAACTTGGATATGGATATTG-3'

 

reverse

5'-CCGACTAGT TACCAAGAGCCTCATCGAGT-3'

F8

forward

5'-CCGCCATGG CTAAACTTCAA-3'

 

reverse

5'-CCGACTAGT TAATTCAAGATCAAGAT-3'

NLS1

forward

5'-CATGG GGAAGAGGAAGAATTCGTCTTCCGCGAGT

TCTTTTGCAGAACAGGAACACAGAAAGAAAA-3'

 

reverse

5'-CTAGT TTTCTTTCTGTGTTCCTGTTCTGCAAAAGAA

CTCGCGGAAGACGAATTCTTCCTCTTCCC-3'

NLS2

forward

5'-CATGG AGAACAAGAACAAGAAAAGGCCATCTA-3'

 

reverse

5'-CTAGT AGATGGCCTTTTCTTGTTCTTGTTCTC-3'

NLS3

forward

5'-CATGG AGAAACGGCCTAGGAAGAGGA-3'

 

reverse

5'-CTAGT CCTCTTCCTAGGCCGTTTCTC-3'

NLS4

forward

5'-CATGG AGGCAGAGAGGCAGAGGAGGGAGAAGTTGA-3'

 

reverse

5'-CTAGT CAACTTCTCCCTCCTCTGCCTCTCTGCCTC-3'

  1. Underlined sequences represent the positions of the restriction sites used for cloning the PCR products into the GFP-pEMBL18 or pTH2BN vectors.